• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺纤维化患者血清血管生成活性与肺功能的关系。

Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function.

机构信息

Department of Family Medicine, Warsaw Medical University, Warsaw, Poland.

出版信息

Eur J Med Res. 2010 Nov 4;15 Suppl 2(Suppl 2):229-34. doi: 10.1186/2047-783x-15-s2-229.

DOI:10.1186/2047-783x-15-s2-229
PMID:21147657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4360317/
Abstract

OBJECTIVE

Chronic inflammation and fibrosis are characteristic of interstitial lung diseases (ILD) and are accompanied by neovascularisation. The aim of this study was to examine the relationship between the angiogenic activity of sera from ILD patients and pulmonary function tests.

MATERIAL AND METHODS

Serum samples were obtained from 225 ILD patients: 83 with sarcoidosis, 31 with idiopathic pulmonary fibrosis, 29 with extrinsic allergic alveolitis, 16 with collagen vascular diseases, 13 with scleroderma with pulmonary manifestations (SCL), 14 with Wegener's granulomatosis (WG), 12 with silicosis, 12 with pulmonary Langerhans cells histiocytosis, 10 with drug-induced pulmonary fibrosis, 5 with cryptogenic organizing pneumonia, and 36 healthy volunteers. An animal model of leukocyte induced angiogenesis assay was used as an angiogenic test. In all patients spirometry, whole body plethysmography, static lung compliance, and single breath diffusing capacity of the lungs for carbon monoxide (DLco) were performed.

RESULTS

The angiogenic properties of sera from ILD differed, depending on the disease. In the examined ILD, the most important functional disturbances were decreases in static compliance and DLco. The correlation between DLco and angiogenic activity of sera was observed (P<0.05).

CONCLUSIONS

The data show that sera from ILD patients constitute a source of mediators modulating angiogenesis. Angiogenic activity of sera of ILD patients is related to DLco.

摘要

目的

慢性炎症和纤维化是间质性肺疾病(ILD)的特征,伴有新生血管形成。本研究旨在探讨ILD 患者血清的血管生成活性与肺功能测试之间的关系。

材料和方法

从 225 名ILD 患者中获得血清样本:83 名结节病患者,31 名特发性肺纤维化患者,29 名外源性过敏性肺泡炎患者,16 名胶原血管疾病患者,13 名有肺部表现的硬皮病患者(SCL),14 名韦格纳肉芽肿(WG)患者,12 名矽肺患者,12 名肺朗格汉斯细胞组织细胞增生症患者,10 名药物性肺纤维化患者,5 名隐源性机化性肺炎患者,36 名健康志愿者。使用白细胞诱导的血管生成测定作为血管生成试验。在所有患者中进行了肺量计检查、全身体积描记法、静态肺顺应性和一氧化碳单呼吸弥散量(DLco)。

结果

ILD 患者血清的血管生成特性因疾病而异。在所检查的ILD 中,最重要的功能障碍是静态顺应性和 DLco 的降低。观察到 DLco 与血清血管生成活性之间存在相关性(P<0.05)。

结论

数据表明,ILD 患者的血清构成了调节血管生成的介质来源。ILD 患者血清的血管生成活性与 DLco 相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5529/4360317/0b9551799811/2047-783X-15-S2-229-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5529/4360317/f42a333c5f84/2047-783X-15-S2-229-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5529/4360317/2c0baf5089cc/2047-783X-15-S2-229-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5529/4360317/0b9551799811/2047-783X-15-S2-229-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5529/4360317/f42a333c5f84/2047-783X-15-S2-229-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5529/4360317/2c0baf5089cc/2047-783X-15-S2-229-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5529/4360317/0b9551799811/2047-783X-15-S2-229-3.jpg

相似文献

1
Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function.特发性肺纤维化患者血清血管生成活性与肺功能的关系。
Eur J Med Res. 2010 Nov 4;15 Suppl 2(Suppl 2):229-34. doi: 10.1186/2047-783x-15-s2-229.
2
Angiogenic activity of sera from interstitial lung disease patients in relation to clinical and radiological changes.间质性肺疾病患者血清的血管生成活性与临床和影像学变化的关系。
Eur J Med Res. 2009 Dec 7;14 Suppl 4(Suppl 4):259-64. doi: 10.1186/2047-783x-14-s4-259.
3
TNFalpha and INFgamma inducing capacity of sera from patients with interstitial lung disease in relation to its angiogenesis activity.间质性肺疾病患者血清的肿瘤坏死因子α和干扰素γ诱导能力与其血管生成活性的关系
J Physiol Pharmacol. 2007 Nov;58 Suppl 5(Pt 2):767-80.
4
Angiogenic activity of sera from silicosis and pulmonary Langerhans cell histiocytosis patients in relation to lung function tests.矽肺和肺朗格汉斯细胞组织细胞增多症患者血清的血管生成活性与肺功能测试的关系
J Physiol Pharmacol. 2008 Dec;59 Suppl 6:781-9.
5
Influence of sera from interstitial lung disease patients on angiogenic activity of mononuclear cells.间质肺病患者血清对单个核细胞血管生成活性的影响。
Adv Exp Med Biol. 2013;756:139-45. doi: 10.1007/978-94-007-4549-0_18.
6
Angiogenic activity of sera from interstitial lung disease patients in relation to angiotensin-converting enzyme activity.特发性肺间质纤维化患者血清血管生成活性与血管紧张素转换酶活性的关系
Adv Exp Med Biol. 2013;756:213-21. doi: 10.1007/978-94-007-4549-0_27.
7
Modulatory effect of sera from patients with various types of pulmonary fibrosis on mononuclear cell induced angiogenesis in relation to pulmonary function.不同类型肺纤维化患者血清对单核细胞诱导血管生成的调节作用及其与肺功能的关系
J Physiol Pharmacol. 2008 Dec;59 Suppl 6:771-9.
8
Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis.系统性硬化症患者肺弥散功能受损的决定因素
Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S80-6. Epub 2015 Apr 16.
9
[Single-breath and rebreathing methods for measurement of pulmonary diffusing function: a comparative study].[单次呼吸法和重复呼吸法测量肺弥散功能的比较研究]
Zhonghua Jie He He Hu Xi Za Zhi. 2013 Jul;36(7):510-5.
10
[Evaluation of angiogenic activity in sera from patients with interstitial lung diseases].[间质性肺疾病患者血清血管生成活性的评估]
Pneumonol Alergol Pol. 1997;65(11-12):754-60.

引用本文的文献

1
Greater Large Conducting Airway Luminal Area in Patients with Interstitial Lung Disease.间质性肺疾病患者的大气道管腔面积增大
medRxiv. 2025 Apr 6:2025.04.04.25324181. doi: 10.1101/2025.04.04.25324181.
2
Functions of exogenous FGF signals in regulation of fibroblast to myofibroblast differentiation and extracellular matrix protein expression.外源性 FGF 信号在调节成纤维细胞向肌成纤维细胞分化和细胞外基质蛋白表达中的作用。
Open Biol. 2022 Sep;12(9):210356. doi: 10.1098/rsob.210356. Epub 2022 Sep 14.
3
Respiratory Impedance is Associated with Ventilation and Diffusing Capacity in Patients with Idiopathic Pulmonary Fibrosis Combined with Emphysema.

本文引用的文献

1
Lung volumes and forced ventilatory flows.肺容积与用力通气流量
Eur Respir J. 1993 Mar;6 Suppl 16:5-40. doi: 10.1183/09041950.005s1693.
2
Angiogenic activity of sera from interstitial lung disease patients in relation to clinical and radiological changes.间质性肺疾病患者血清的血管生成活性与临床和影像学变化的关系。
Eur J Med Res. 2009 Dec 7;14 Suppl 4(Suppl 4):259-64. doi: 10.1186/2047-783x-14-s4-259.
3
Soluble endostatin is a novel inhibitor of epithelial repair in idiopathic pulmonary fibrosis.可溶性内皮抑素是特发性肺纤维化中上皮修复的一种新型抑制剂。
特发性肺纤维化合并肺气肿患者的呼吸阻抗与通气和弥散能力相关。
Int J Chron Obstruct Pulmon Dis. 2022 Jul 1;17:1495-1506. doi: 10.2147/COPD.S368162. eCollection 2022.
4
Oscillometry and computed tomography findings in patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者的振荡法和计算机断层扫描结果
ERJ Open Res. 2020 Dec 14;6(4). doi: 10.1183/23120541.00391-2020. eCollection 2020 Oct.
5
Low-Frequency Intrapulmonary Percussive Ventilation Increases Aerosol Penetration in a 2-Compartment Physical Model of Fibrotic Lung Disease.低频肺内叩击通气增加纤维化肺病双室物理模型中的气溶胶渗透
Front Bioeng Biotechnol. 2020 Aug 28;8:1022. doi: 10.3389/fbioe.2020.01022. eCollection 2020.
6
Matrix abnormalities in pulmonary fibrosis.肺纤维化中的基质异常。
Eur Respir Rev. 2018 Jun 27;27(148). doi: 10.1183/16000617.0033-2018. Print 2018 Jun 30.
7
Physiology of the lung in idiopathic pulmonary fibrosis.特发性肺纤维化的肺生理学。
Eur Respir Rev. 2018 Jan 24;27(147). doi: 10.1183/16000617.0062-2017. Print 2018 Mar 31.
8
Immunoexpression of TGF-β/Smad and VEGF-A proteins in serum and BAL fluid of sarcoidosis patients.结节病患者血清和支气管肺泡灌洗液中TGF-β/Smad和VEGF-A蛋白的免疫表达
BMC Immunol. 2015 Oct 6;16:58. doi: 10.1186/s12865-015-0123-y.
Thorax. 2009 Feb;64(2):156-61. doi: 10.1136/thx.2008.102814. Epub 2008 Oct 13.
4
Modulatory effect of sera from sarcoidosis patients on mononuclear cell-induced angiogenesis.结节病患者血清对单核细胞诱导的血管生成的调节作用。
J Physiol Pharmacol. 2007 Nov;58 Suppl 5(Pt 2):753-66.
5
Inflammation and ischemia-induced lung angiogenesis.炎症和缺血诱导的肺血管生成。
Am J Physiol Lung Cell Mol Physiol. 2008 Feb;294(2):L351-7. doi: 10.1152/ajplung.00369.2007. Epub 2007 Dec 21.
6
Expansion of regulatory T cells in patients with Langerhans cell histiocytosis.朗格汉斯细胞组织细胞增多症患者中调节性T细胞的扩增。
PLoS Med. 2007 Aug;4(8):e253. doi: 10.1371/journal.pmed.0040253.
7
Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice.沙利度胺可预防博来霉素诱导的小鼠肺纤维化。
J Immunol. 2007 Jul 1;179(1):708-14. doi: 10.4049/jimmunol.179.1.708.
8
Current concepts in normal and defective angiogenesis: implications for systemic sclerosis.正常及异常血管生成的当前概念:对系统性硬化症的影响
Curr Rheumatol Rep. 2007 May;9(2):173-9. doi: 10.1007/s11926-007-0013-2.
9
Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis.结节病和特发性肺纤维化中不同的血管生成活性。
Chest. 2006 Oct;130(4):982-8. doi: 10.1378/chest.130.4.982.
10
Critical roles of capillary endothelial cells for alveolar remodeling in nonspecific and usual interstitial pneumonias.毛细血管内皮细胞在非特异性间质性肺炎和普通型间质性肺炎肺泡重塑中的关键作用。
J Nippon Med Sch. 2006 Aug;73(4):203-13. doi: 10.1272/jnms.73.203.